A, TSG-6 staining in TRAMP tissue and TRAMP cell lines.

Slides:



Advertisements
Similar presentations
Neal et al.Supplementary Figure S1
Advertisements

AZD9291 inhibits EGFR phosphorylation and downstream signaling in murine models of EGFRT790M-resistant lung cancer. AZD9291 inhibits EGFR phosphorylation.
Overexpression of ornithine decarboxylase enhances endothelial proliferation by suppressing endostatin expression by Takahiro Nemoto, Hisae Hori, Masataka.
25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.
PD-1 and LAG-3 expression in MSI and MSS colorectal cancer specimens.
Increase in beige/brown adipocyte characteristics in the xenografts from additional breast cancer cell lines. Increase in beige/brown adipocyte characteristics.
NICD1 immunohistochemical staining in normal and tumor tissue.
Treatment with MI-773 causes changes in p53 status.
Effect of MI-773 and/or cisplatin in a preclinical model of ACC
Expression changes of specific epigenetic-controlled tumor-related genes by the prenatal/maternal BSp treatment. qRT-PCR and Western blot analysis were.
Effect of MI-773 dosing on long-term efficacy.
SIRT1 is downregulated in human gastric cancer (GC).
Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal tumors. Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal.
TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.
Effects of PS-341 on apoptosis in orthotopic human pancreatic tumors.
The expression of SPINDLIN1 in cancer tissues.
CDCP1 is required for invadopodia formation and ECM degradation by human breast cancer cells. CDCP1 is required for invadopodia formation and ECM degradation.
E-cadherin synthetic lethal effects operate in vivo in E-cadherin–defective breast tumors. E-cadherin synthetic lethal effects operate in vivo in E-cadherin–defective.
Silencing hOGG1 triggers caspase-3 and caspase-7 activation in response to H2O2 in GM00637 cells. Silencing hOGG1 triggers caspase-3 and caspase-7 activation.
FAK overexpression in invasive human breast cancer and DCIS
FAK overexpression in invasive human colon cancer and colon dysplasia.
Geldanamycin-induced endocytosis and down-regulation of ErbB2 in cells expressing ErbB2 only. Geldanamycin-induced endocytosis and down-regulation of ErbB2.
VEGF expression in neoplastic and normal prostate tissue.
A, one-step viral growth curves: RT treatment increased the virus yield in MV-CEA–treated U87 cells by up to 2 log as compared with MV-CEA infection only.
Antitumor activity of MLN8237 against TNBC patient-derived tumor xenografts (PDTX) in vivo. Antitumor activity of MLN8237 against TNBC patient-derived.
Transplantable HMLEHRASV12 xenografts show multilocular lipid droplets and express beige/brown adipocyte–specific proteins. Transplantable HMLEHRASV12.
Anti-Flk-1 mAb treatment reduces vessel density in tumors.
Cisplatin plus PTUPB decreases proliferation and angiogenesis but increases apoptosis as determined by immunohistochemical (IHC) analysis. Cisplatin plus.
PVHA increased anti-PD-L1–mediated growth inhibition in 4T1/HAS3 tumors. PVHA increased anti-PD-L1–mediated growth inhibition in 4T1/HAS3 tumors. A, 4T1/HAS3.
Effect of SFN on the protein expression of Nrf2, HO-1, and NQO1 in JB6-shMock and JB6-shNrf2 cells. Effect of SFN on the protein expression of Nrf2, HO-1,
IGF-IR in human head and neck cancer.
Src expression in a panel of human TCC cell lines.
Expression pattern of TLR-4 and MyD88 in EOC cells.
Activation of mTOR signaling (increased phosphorylated S6 ribosomal protein) and loss of inhibition of IRS-1 in human endometrial carcinomas. Activation.
Immunohistochemical analysis of dUTPase in human breast adenocarcinoma
Visualization of tumor vasculature using anti-CD31 immunohistochemistry. Visualization of tumor vasculature using anti-CD31 immunohistochemistry. Micrographs.
Ketogenic diets combined with fractionated radiation treatment results in decreased immunoreactive PCNA in tumor tissue. Ketogenic diets combined with.
SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression. SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression.
Isolation of stable XPAKD and XPCKD HeLa clones.
Reduced klotho expression in pancreatic cancer.
Expression of the cell death markers activated caspase-3 and LC3 I/II in TUBO cells. Expression of the cell death markers activated caspase-3 and LC3 I/II.
Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors. Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors.
Effect of CDV on human SF7796 xenografts in vivo.
Combined inhibition of coamplified RTKs is required for response.
CDV potentiates the antitumor effect of ionizing radiation in mice intracerebrally implanted with human glioblastoma cells. CDV potentiates the antitumor.
Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.
Progastrin staining in colon adenomas and adenocarcinomas.
AS1411 alters subcellular distribution of PRMT5 in a time-dependent, dose-dependent, and nucleolin-dependent manner. AS1411 alters subcellular distribution.
A, TSG-6 staining in human prostate.
In vivo effects of TTFields on intradermal tumors in mice.
Effect of MZ treatment on lung colony formation in an experimental metastasis. Effect of MZ treatment on lung colony formation in an experimental metastasis.
Interaction of NHEJ and HR pathways in PCO cultures.
BEZ235 induces accelerated senescence after radiation (IR) in vitro.
Effects of ZOL treatment on pulmonary metastases.
RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis in ovarian cancer cells. RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis.
Blockade of cell cycle at G2-M phase in Bel-7402 cells treated with IG-105. Blockade of cell cycle at G2-M phase in Bel-7402 cells treated with IG-105.
Cabozantinib causes significant tumor cell elimination in vivo, but modest apoptosis induction in vitro. Cabozantinib causes significant tumor cell elimination.
Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated breast cancer cells. Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated.
Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells. Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells.
Recruitment of CD8+, CD4+, and Foxp3+ cells into oral lesions in response to anti–PD-1 treatment. Recruitment of CD8+, CD4+, and Foxp3+ cells into oral.
Effect of SFN on the total activity and protein expression of HDACs in JB6 P+ cells. Effect of SFN on the total activity and protein expression of HDACs.
CD36 expression is coordinately regulated in multiple cellular compartments. CD36 expression is coordinately regulated in multiple cellular compartments.
CD36 expression in tissue adjacent and distal to the tumor.
TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3 pathway. TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3.
I3C reduces the level of Cdc25A protein in breast cancer cells.
Expression of the angiogenic phenotype in the 4-NQO mouse model of HNSCC. A, tissue sections containing areas of normal, hyperkeratosis, dysplasia, and.
Effect of 6-SHO on mouse prostate cancer HMVP2 cells.
Determination of Per2 (left), MTNR1A (middle), and ERβ (right) protein expression levels in mammary tissues of rats sacrificed at ZT12. Determination of.
Determination of O2− production by H&E staining using confocal fluorescence microscope. Determination of O2− production by H&E staining using confocal.
Time course of NMT knockdown.
Presentation transcript:

A, TSG-6 staining in TRAMP tissue and TRAMP cell lines. A, TSG-6 staining in TRAMP tissue and TRAMP cell lines. Paraffin-embedded tissues sections were deparaffinized with xylene and rehydrated using graded ethanol and used in immunohistochemistry as described in Materials and Methods. i, no TSG-6 staining in the prostate from animal on normal diet. Magnification, ×40. ii, TSG-6 expression in prostate from a representative animal on 2-methoxyestradiol diet that showed positive staining. B, TSG-6 in TRAMP mouse prostate cancer cells. TRAMP C2, mouse prostate cells were either treated with 2-methoxyestradiol (3 μmol/L) for 24 hours or left untreated (solvent control). Following treatment, cells were harvested and fixed in 10% buffered formalin, and immunocytochemical analysis was done as described in Materials and Methods. Staining indicative of TSG-6 expression was detected only in cells treated with 2-methoxyestradiol. Untreated cells showed very little or no staining. C, Western blot analysis of TSG-6. TSG-6 expression was determined in TRAMP tumors (control) or prostate tissue (2-methoxyestradiol–fed animals) depending on the case using Western blot analysis. Data was quantified using Scion image analysis program. Gretchen E. Garcia et al. Clin Cancer Res 2006;12:980-988 ©2006 by American Association for Cancer Research